OQS
INMB icon

Occudo Quantitative Strategies’s INmune Bio INMB Stock Holding History

Occudo Quantitative Strategies’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,482
Closed -$72.7K – 803
2024
Q3 		$72.7K Buy
+13,482
New +$95.8K 0.01% 654

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Occudo Quantitative Strategies's INMB Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of INmune Bio (INMB) in Q4 2024, closing a stake of 13,482 shares — an estimated $72.7K sold.

Occudo Quantitative Strategies first reported a position in INMB in Q3 2024 and held it in 1 quarter. The position peaked at $72.7K in Q3 2024. 73 funds tracked by Wall St. Rank hold INMB as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining INmune Bio position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,482 INmune Bio shares in Q4 2024, an estimated $72.7K.
  • Occudo Quantitative Strategies first reported a position in INmune Bio in Q3 2024 and held it in 1 quarter.
  • Occudo Quantitative Strategies's INmune Bio position peaked at $72.7K in Q3 2024.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.